trending Market Intelligence /marketintelligence/en/news-insights/trending/wzzuedcjrhpuhwx5enjo1a2 content esgSubNav
In This List

Alnylam Pharmaceuticals names board member

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Alnylam Pharmaceuticals names board member

Cambridge, Mass.-based biopharmaceutical company Alnylam Pharmaceuticals Inc. appointed Colleen Reitan to its board, effective June 1.

Reitan was previously president of plan operations of Health Care Service Corp., a Chicago-based health and life insurance provider.